RxDoctor Payments Data

Chandhana Paka, MD

Urogynecology and Reconstructive Pelvic Surgery · New York, NYNPI 1063746840

Payments from drug & device makers

What this record shows

This record is dominated by other: $3,000 of the $3,766 with a category attached, or 79.7%. Intuitive Surgical accounts for 80.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $3,162 and has fallen 99.3% since, to $21 in 2025.

$3,766in general payments, 2019–2025

Across 16 payments — averaging $235.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • Coloplast$284
  • Medtronic$130
  • Boston Scientific$116
  • Axonics, Inc.$115
  • AbbVie$52
  • plus $35 from 2 others

What the payments were for

  • Food & beverage$75120%
  • Education$150%
  • Other$3,00080%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,766 in reported general payments places this provider in the 60th percentile of 90 urogynecology and reconstructive pelvic surgery providers in New York.

See all urogynecology and reconstructive pelvic surgery providers in New York

Medicare billing

Part B allowed, 2024
$29,922
Medicare patients
96
Services billed
252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron64$48,970
Estradiol131$10,436
ValacyclovirValacyclovir Hcl12$524
Nystatin19$199
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$71
Triamcinolone Acetonide20$66

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →